MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-08-0002906
Sunglow Lifescience Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.84 Cr
▼ 2% YoY
Net profit · FY 2025
₹4.42 Cr
Net margin 6.4%
EBITDA · FY 2025
₹8.69 Cr
EBITDA margin 12.6%
Authorised capital
₹21 Cr
Registered with MCA
Paid-up capital
₹20.45 Cr
Issued & subscribed
Open charges
₹18.64 Cr
Satisfied ₹13.45 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
109
Provident fund records
About Sunglow Lifescience Private Limited
Data last updated:
Sunglow Lifescience Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2012PTC087894. Its GSTIN is 33AASCS1711K1Z8 (Tamil Nadu).
The company has an authorised share capital of ₹21 Cr and a paid-up capital of ₹20.45 Cr. It is led by directors including Veerabadran Rajasekaran and S Arvind Bhandari.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.84 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹4.42 Cr (net margin 6.4%) and EBITDA of ₹8.69 Cr (EBITDA margin 12.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The company has about 109 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹18.64 Cr and satisfied charges of ₹13.45 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 11 deals on record (5 funding rounds, 5 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.99 Cr; the latest was in September 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Maxheal Laboratories Private Limited with revenue of ₹69.71 Cr. The company has 4 MSME Form 1 returns on record between 2017 and 2019, listing 135 overdue payments to 131 micro and small suppliers.
Sunglow Lifescience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0002906). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunglowlifescience.com.
Company details
CIN U24100TN2012PTC087894
Registration Number 087894
Incorporation Date 01 October 2012
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-08-0002906
Recognitions & Rankings of Sunglow Lifescience
Contact details
Sunglow Lifescience Private Limited's registered office is in Chennai, Tamil Nadu. Its website is sunglowlifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address8th Floor Kaleesuwari Towers No 10/98A Pace Aagam Apartments, Velachery Main Road Ranganathapuram, Chennai, Tamil Nadu, India – 600100
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunglow Lifescience Private Limited, buy the company report.
Comprehensive company report
Sunglow Lifescience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sunglow Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunglow Lifescience Private Limited, buy the company report.
Financials of Sunglow Lifescience Private Limited
FY 2025 filings availableSunglow Lifescience Private Limited reported revenue of ₹68.84 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹68.84 Cr ▼ 2%
Net profit · FY 2025
₹4.42 Cr margin 6.4%
EBITDA · FY 2025
₹8.69 Cr margin 12.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 3%
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.69 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.6% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunglow Lifescience Private Limited, buy the company report.
Board of directors of Sunglow Lifescience Private Limited
Sunglow Lifescience has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veerabadran Rajasekaran Also directs: Sunglow Pharmaceuticalss Private Limited | Director | 09 Sep 2013 | 13 Years 1 Months | Current |
| S Arvind Bhandari Also directs: Adiramedica Private Limited | Director | 28 Nov 2013 | 12 Years 10 Months | Current |
| Rajasekar Nagamallu Also directs: Stepspace Builders LLP, Pace Builders (Madras) Private Limited | Director | 28 Jul 2021 | 5 Years 2 Months | Current |
| Kamaraj Also directs: Apex Innotech LLP, Sunglow Pharmaceuticalss Private Limited | Director | 01 Oct 2012 | 14 Years 0 Months | Current |
Peer comparison
Sunglow Lifescience Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxheal Laboratories Private Limited | ₹69.71 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Sanjivani Biochem Private Limited | ₹69.17 Cr (FY 2025) | 64.0% | Ahmedabad, Gujarat, India | |||
| Three B Healthcare Limited | ₹68.95 Cr (FY 2024) | -2.0% | New Delhi, Delhi, India | |||
| Sunglow Lifescience Private Limitedthis company | ₹68.84 Cr (FY 2025) | ₹4.42 Cr | 6.4% | -2.0% | 109 | Chennai, Tamil Nadu, India |
| Swift Life Sciences Private Limited | ₹68.84 Cr (FY 2025) | 109.0% | Dehradun, Uttarakhand, India | |||
| Merit Organics Limited | ₹68.45 Cr (FY 2025) | -5.0% | Mumbai, Maharashtra, India | |||
| Super Lifecare Private Limited | ₹68.31 Cr (FY 2025) | -16.0% | Ahmedabad, Gujarat, India | |||
| Oxford Laboratories Private Limited | ₹67.77 Cr (FY 2025) | 26.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sunglow Lifescience Private Limited, buy the company report.
Auditor
Sunglow Lifescience Private Limited is audited by Betala & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Betala & Associates | FY 2024 | 011580S |
Shareholding
The shareholding of Sunglow Lifescience Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sunglow Lifescience Private Limited, buy the company report.
Charges & borrowings
Open charges
₹18.64 Cr
Satisfied charges
₹13.45 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Apr 2025 | 101098270 | Hdfc Bank Limited | ₹37.69 Lakh | Open | |
| 23 Jul 2020 | 100360500 | Axis Bank Limited | ₹18.26 Cr | Open | |
| 28 Feb 2017 | 100087370 | Axis Bank Limited | ₹13.45 Cr | Satisfied |
To see the full charge records of Sunglow Lifescience Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Sunglow Lifescience Private Limited has 11 deals on record (5 funding rounds, 5 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.99 Cr; the latest was in September 2024.
Total deals
11
Funding rounds
5
Secondary share transfers
5
Rights issue
1
Disclosed funding
₹19.99 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Apr 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Sunglow Lifescience Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sunglow Lifescience Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kancheepuram, Tamil Nadu | Civil suit | Filed against the company by Novartis Ag, Mr.Atul Bade | Disposed |
To see the full case history of Sunglow Lifescience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sunglow Lifescience Private Limited has 4 MSME Form 1 returns on record between 2017 and 2019, listing 135 overdue payments to 131 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 131)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Pac Nation | |||
| an individual supplier | |||
| Sai Baba Business Solutions Private Limited |
To see the full MSME payment records of Sunglow Lifescience Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sunglow Lifescience has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Sunglow Pharmaceuticalss Private Limited | U24232PY2010PTC002407 |
To see the full group structure of Sunglow Lifescience Private Limited, buy the company report.
Employees & EPFO
Sunglow Lifescience Private Limited has a workforce of 109 employees on its EPFO records as of Mar 07, 2025, across 1 active EPFO establishment.
Employee count
109
Active EPFO establishments
1
Employee growth
11.22%
GST
Sunglow Lifescience has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AASCS1711K1Z8 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sunglow Lifescience Private Limited, buy the company report.
Recent activity
Sunglow Lifescience Private Limited has 9 board changes on record since 2012: 5 appointments and 4 cessations. The latest: Narayanan Agaram Seetharaman was appointed as Company Secretary on 20 Mar 2025.
AGM
Sunglow Lifescience Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 18.26 Cr registered on 23 Jul 2020 with Charge ID 100360500 was modified on 12 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.38 Cr with Charge ID 101098270 was registered on 04 Apr 2025.
Filing
Sunglow Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Narayanan Agaram Seetharaman was appointed as Company Secretary.
Charges
A charge registered on 28 Feb 2017 via Charge ID 100087370 with Axis Bank Limited was fully satisfied on 14 Mar 2025.
Charges
A charge with Axis Bank Limited of Rs. 13.45 Cr registered on 28 Feb 2017 with Charge ID 100087370 was modified on 12 Oct 2023.
Ceased
Rajasekar Nagamallu ceased to be Additional Director.
Appointed
Rajasekar Nagamallu was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 18.26 Cr with Charge ID 100360500 was registered on 23 Jul 2020.
Ceased
Kandoth Kunnumpreth Vinupal ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 13.45 Cr with Charge ID 100087370 was registered on 28 Feb 2017.
6 earlier events are in the company report.
Frequently asked questions
Sunglow Lifescience is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 October 2012 (14+ years old) and is registered under CIN U24100TN2012PTC087894.
Sunglow Lifescience has 4 current directors:
- Veerabadran Rajasekaran - Director
- S Arvind Bhandari - Director
- Rajasekar Nagamallu - Director
- Kamaraj - Director
The latest financial statements of Sunglow Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunglow Lifescience is 33AASCS1711K1Z8, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Sunglow Lifescience is U24100TN2012PTC087894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunglow Lifescience has 1 court case on record: 1 filed against it.
Sunglow Lifescience was incorporated on 01 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
Sunglow Lifescience has 11 deals on record (5 funding rounds, 5 secondary share transfers, 1 rights issue), with disclosed funding of ₹19.99 Cr; the latest was in September 2024.
The peers of Sunglow Lifescience by revenue are Maxheal Laboratories Private Limited, Sanjivani Biochem Private Limited, Three B Healthcare Limited, Swift Life Sciences Private Limited, Merit Organics Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narayanan Agaram Seetharaman was appointed as Company Secretary on 20 Mar 2025. Rajasekar Nagamallu ceased to be Additional Director on 10 Nov 2021. Rajasekar Nagamallu was appointed as Director on 28 Jul 2021. Sunglow Lifescience has 9 board changes on record in total.
Yes, Sunglow Lifescience is registered as a small enterprise under Udyam registration (number: UDYAM-TN-08-0002906).
Sunglow Lifescience has 4 MSME Form 1 returns on record between 2017 and 2019, listing 135 overdue payments to 131 micro and small suppliers. The latest return was filed on 02 Jun 2019.